Auph stock zacks
AUPH | Complete Aurinia Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. 12/18/2019 · Find the latest Aurinia Pharmaceuticals Inc (AUPH) stock quote, history, news and other vital information to help you with your stock trading and investing. 7 brokerages have issued 1 year price targets for Aurinia Pharmaceuticals' stock. Their forecasts range from $11.00 to $32.00. On average, they expect Aurinia Pharmaceuticals' stock price to reach $21.50 in the next twelve months. This suggests a possible upside of 6.1% from the stock's current price. Get breaking news and analysis on Aurinia Pharmaceuticals Inc. (AUPH) stock, price quote and chart, trading and investing tools. The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style. We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating:
12/2/2019 · Zacks Investment Research upgraded shares of Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) from a sell rating to a hold rating in a research report sent to investors on Thursday, Zacks.com reports. According to Zacks, “Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company.
12/23/2019 · Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Aurinia Pharmaceuticals Inc. company facts, information and stock details by MarketWatch. View auph business summary and other industry information. AUPH, Aurinia Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Find real-time AUPH - Aurinia Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Aurinia Pharmaceuticals (AUPH) Catches Eye: Stock Jumps 6.2% Zacks Oct-16-19 06:30AM Aurinia Reports Last Patient Study Visit in Aurora Phase 3 Lupus Nephritis Study and Provides Update on ATM Facility Business Wire +6.21%
AUPH | Complete Aurinia Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
The latest closing stock price for Aurinia Pharmaceuticals Inc as of December 30, 2019 is 20.24. The all-time high Aurinia Pharmaceuticals Inc stock closing price was 21.42 on December 27, 2019. The Aurinia Pharmaceuticals Inc 52-week high stock price is 21.93, which is 8.3% above the current share price. Zacks Investment Research upgraded shares of Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) from a hold rating to a buy rating in a research report sent to investors on Tuesday, Zacks.com reports. They currently have $7.00 price target on the biotechnology company’s stock. Analysts expect that Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) (TSE:AUP) will report earnings per share (EPS) of ($0.16) for the current fiscal quarter, Zacks Investment Research reports. Four analysts have made estimates for Aurinia Pharmaceuticals’ earnings, with estimates ranging from ($0.22) to ($0.10).
Implied Volatility Surging For Aurinia Pharmaceuticals (AUPH) Stock Options By Zacks Investment Research - Oct 16, 2017. Investors in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 20, 2017 $5 Call had some of the
AUPH | Complete Aurinia Pharmaceuticals Inc. stock news by MarketWatch. AUPH U.S.: Nasdaq. ETFs higher. Dec. 10, 2019 at 4:16 p.m. ET on Zacks.com Get breaking news and analysis on Aurinia Pharmaceuticals Inc. (AUPH) stock, price quote and chart, trading and investing tools. at Zacks.com (Dec 2, 2019). Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Aurinia Pharmaceuticals Inc have a median target of 24.00, with a high estimate of Get today's Aurinia Pharmaceuticals Inc stock price and latest AUPH news as well as Aurinia Pharma real-time stock quotes, Zacks Investment Research. Stocks With This Characteristic Are Very Rare - But We Found One. Aurinia Pharmaceuticals (AUPH) Catches Eye: Stock Jumps 9.8%. Zacks The latest closing stock price for Aurinia Pharmaceuticals Inc as of December 31, 2019 is 20.26. The all-time high Aurinia last 52 weeks is 7.08. Compare AUPH With Other Stocks. Fundamental data from Zacks Investment Research, Inc. Zacks , 4:16 PM EST Aurinia's Lupus Candidate Succeeds in Pivotal Study, Stock Up Aurinia Pharmaceuticals (AUPH) Catches Eye: Stock Jumps 9.8%.
Detailed price information for Aurinia Pharm Ord (AUPH-Q) from The Globe and Aurinia Pharmaceuticals stock surges on positive clinical results for lupus drug Corporate earnings are provided from Zacks Investment Research, including
Stocks With This Characteristic Are Very Rare - But We Found One. Aurinia Pharmaceuticals (AUPH) Catches Eye: Stock Jumps 9.8%. Zacks
View Aurinia Pharmaceuticals Inc AUPH investment & stock information. Get the latest Aurinia Pharmaceuticals Inc AUPH detailed stock quotes, stock data, Use the Zacks Rank and Style Scores to find out is AUPH is right for your portfolio. Quote Overview » Zacks Research » Aurinia Pharmaceuticals Inc (AUPH) Style Scores Aurinia Pharmaceuticals (AUPH) Catches Eye: Stock Jumps 9.8%. AUPH: Aurinia Pharmaceuticals Inc broker recommendation chart. Get the latest chart with broker recommendations from Zacks Investment Research. Aurinia Pharmaceuticals (AUPH) Reports Q3 Loss, Tops Revenue Estimates. by Zacks Equity Research Published on November 14,2019. Aurinia (AUPH)